Definitive Healthcare Corp

How CFO insider sales on May 1, 2026 reveal insider confidence in Definitive Healthcare’s tech‑driven future, despite a muted market reaction.

Definitive Healthcare insider sales reveal tax‑planning moves amid a 6% month‑to‑date drop, yet the company’s data‑driven health‑tech model and expanding payer contracts could cushion the decline and sustain long‑term growth.

CEO Kevin Coop’s March 2026 sale of 175,524 shares shows a tax‑driven, routine move that left him still holding 5 M+ shares—an insider stance that balances modest volatility and bullish leadership buying amid a competitive health‑analytics market.

Insider selling of Definitive Healthcare shares raises doubts about the firm’s near‑term outlook—learn what this pattern signals for investors and when to watch next.